Muscle performance, size, and safety responses after eight weeks of resistance training and protein supplementation

A randomized, double-blinded, placebo-controlled clinical trial

Ashley A. Herda, Trent J. Herda, Pablo B. Costa, Eric D. Ryan, Jeffrey R. Stout, Joel T Cramer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The purpose of this study was to examine the effects of 2 different types of protein supplementation on thigh muscle cross-sectional area (CSA), blood markers, muscular strength, endurance, and body composition after 8 weeks of low- or moderate-volume resistance training in healthy, recreationally trained, college-aged men. One hundred and six men were randomized into 5 groups: low-volume resistance training with bioenhanced whey protein (BWPLV; n = 22), moderate-volume resistance training with BWP (BWPMV; n = 20), moderate-volume resistance training with standard whey protein (SWPMV; n = 22), moderate-volume resistance training with a placebo (PLA; n = 21), or moderate-volume resistance training with no supplementation (CON; n = 21). Except for CON, all groups consumed 1 shake before and after each exercise session and one each on the nontraining day. The BWPLV, BWPMV, and SWPMV groups received approximately 20 g of whey protein per shake, whereas the BWP groups received 5 g of additional polyethylene glycosylated (PEG) leucine. Resistance training sessions were performed 3 times per week for 8 weeks. There were no interactions (p . 0.05) for muscle strength and endurance variables, body composition, muscle CSA, and safety blood markers, but the main effects for training were observed (p # 0.05). However, the Albumin:Globulin ratio for SWPMV was lower (p = 0.037) than BWPLV and BWPMV. Relative protein intake (PROREL) indicated a significant interaction (p , 0.001) with no differences across groups at pre; however, BWPLV, BWPMV, and SWPMV had a greater intake than did PLA or CON at post (p , 0.001). This study indicated that 8 weeks of resistance training improved muscle performance and size similarly among groups regardless of supplementation.

Original languageEnglish (US)
Pages (from-to)3091-3100
Number of pages10
JournalJournal of strength and conditioning research
Volume27
Issue number11
DOIs
StatePublished - Dec 2 2013

Fingerprint

Resistance Training
Controlled Clinical Trials
Placebos
Safety
Muscles
Proteins
Body Composition
Blood Safety
Globulins
Muscle Strength
Polyethylene
Thigh
Leucine
Albumins
Exercise

Keywords

  • Body composition
  • Leucine
  • Muscle cross-sectional area
  • Strength training
  • Training volume
  • Whey protein

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Muscle performance, size, and safety responses after eight weeks of resistance training and protein supplementation : A randomized, double-blinded, placebo-controlled clinical trial. / Herda, Ashley A.; Herda, Trent J.; Costa, Pablo B.; Ryan, Eric D.; Stout, Jeffrey R.; Cramer, Joel T.

In: Journal of strength and conditioning research, Vol. 27, No. 11, 02.12.2013, p. 3091-3100.

Research output: Contribution to journalArticle

@article{1dfa58ba8b43465483d89038e9fb52d6,
title = "Muscle performance, size, and safety responses after eight weeks of resistance training and protein supplementation: A randomized, double-blinded, placebo-controlled clinical trial",
abstract = "The purpose of this study was to examine the effects of 2 different types of protein supplementation on thigh muscle cross-sectional area (CSA), blood markers, muscular strength, endurance, and body composition after 8 weeks of low- or moderate-volume resistance training in healthy, recreationally trained, college-aged men. One hundred and six men were randomized into 5 groups: low-volume resistance training with bioenhanced whey protein (BWPLV; n = 22), moderate-volume resistance training with BWP (BWPMV; n = 20), moderate-volume resistance training with standard whey protein (SWPMV; n = 22), moderate-volume resistance training with a placebo (PLA; n = 21), or moderate-volume resistance training with no supplementation (CON; n = 21). Except for CON, all groups consumed 1 shake before and after each exercise session and one each on the nontraining day. The BWPLV, BWPMV, and SWPMV groups received approximately 20 g of whey protein per shake, whereas the BWP groups received 5 g of additional polyethylene glycosylated (PEG) leucine. Resistance training sessions were performed 3 times per week for 8 weeks. There were no interactions (p . 0.05) for muscle strength and endurance variables, body composition, muscle CSA, and safety blood markers, but the main effects for training were observed (p # 0.05). However, the Albumin:Globulin ratio for SWPMV was lower (p = 0.037) than BWPLV and BWPMV. Relative protein intake (PROREL) indicated a significant interaction (p , 0.001) with no differences across groups at pre; however, BWPLV, BWPMV, and SWPMV had a greater intake than did PLA or CON at post (p , 0.001). This study indicated that 8 weeks of resistance training improved muscle performance and size similarly among groups regardless of supplementation.",
keywords = "Body composition, Leucine, Muscle cross-sectional area, Strength training, Training volume, Whey protein",
author = "Herda, {Ashley A.} and Herda, {Trent J.} and Costa, {Pablo B.} and Ryan, {Eric D.} and Stout, {Jeffrey R.} and Cramer, {Joel T}",
year = "2013",
month = "12",
day = "2",
doi = "10.1519/JSC.0b013e31828c289f",
language = "English (US)",
volume = "27",
pages = "3091--3100",
journal = "Journal of Strength and Conditioning Research",
issn = "1064-8011",
publisher = "NSCA National Strength and Conditioning Association",
number = "11",

}

TY - JOUR

T1 - Muscle performance, size, and safety responses after eight weeks of resistance training and protein supplementation

T2 - A randomized, double-blinded, placebo-controlled clinical trial

AU - Herda, Ashley A.

AU - Herda, Trent J.

AU - Costa, Pablo B.

AU - Ryan, Eric D.

AU - Stout, Jeffrey R.

AU - Cramer, Joel T

PY - 2013/12/2

Y1 - 2013/12/2

N2 - The purpose of this study was to examine the effects of 2 different types of protein supplementation on thigh muscle cross-sectional area (CSA), blood markers, muscular strength, endurance, and body composition after 8 weeks of low- or moderate-volume resistance training in healthy, recreationally trained, college-aged men. One hundred and six men were randomized into 5 groups: low-volume resistance training with bioenhanced whey protein (BWPLV; n = 22), moderate-volume resistance training with BWP (BWPMV; n = 20), moderate-volume resistance training with standard whey protein (SWPMV; n = 22), moderate-volume resistance training with a placebo (PLA; n = 21), or moderate-volume resistance training with no supplementation (CON; n = 21). Except for CON, all groups consumed 1 shake before and after each exercise session and one each on the nontraining day. The BWPLV, BWPMV, and SWPMV groups received approximately 20 g of whey protein per shake, whereas the BWP groups received 5 g of additional polyethylene glycosylated (PEG) leucine. Resistance training sessions were performed 3 times per week for 8 weeks. There were no interactions (p . 0.05) for muscle strength and endurance variables, body composition, muscle CSA, and safety blood markers, but the main effects for training were observed (p # 0.05). However, the Albumin:Globulin ratio for SWPMV was lower (p = 0.037) than BWPLV and BWPMV. Relative protein intake (PROREL) indicated a significant interaction (p , 0.001) with no differences across groups at pre; however, BWPLV, BWPMV, and SWPMV had a greater intake than did PLA or CON at post (p , 0.001). This study indicated that 8 weeks of resistance training improved muscle performance and size similarly among groups regardless of supplementation.

AB - The purpose of this study was to examine the effects of 2 different types of protein supplementation on thigh muscle cross-sectional area (CSA), blood markers, muscular strength, endurance, and body composition after 8 weeks of low- or moderate-volume resistance training in healthy, recreationally trained, college-aged men. One hundred and six men were randomized into 5 groups: low-volume resistance training with bioenhanced whey protein (BWPLV; n = 22), moderate-volume resistance training with BWP (BWPMV; n = 20), moderate-volume resistance training with standard whey protein (SWPMV; n = 22), moderate-volume resistance training with a placebo (PLA; n = 21), or moderate-volume resistance training with no supplementation (CON; n = 21). Except for CON, all groups consumed 1 shake before and after each exercise session and one each on the nontraining day. The BWPLV, BWPMV, and SWPMV groups received approximately 20 g of whey protein per shake, whereas the BWP groups received 5 g of additional polyethylene glycosylated (PEG) leucine. Resistance training sessions were performed 3 times per week for 8 weeks. There were no interactions (p . 0.05) for muscle strength and endurance variables, body composition, muscle CSA, and safety blood markers, but the main effects for training were observed (p # 0.05). However, the Albumin:Globulin ratio for SWPMV was lower (p = 0.037) than BWPLV and BWPMV. Relative protein intake (PROREL) indicated a significant interaction (p , 0.001) with no differences across groups at pre; however, BWPLV, BWPMV, and SWPMV had a greater intake than did PLA or CON at post (p , 0.001). This study indicated that 8 weeks of resistance training improved muscle performance and size similarly among groups regardless of supplementation.

KW - Body composition

KW - Leucine

KW - Muscle cross-sectional area

KW - Strength training

KW - Training volume

KW - Whey protein

UR - http://www.scopus.com/inward/record.url?scp=84888343497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888343497&partnerID=8YFLogxK

U2 - 10.1519/JSC.0b013e31828c289f

DO - 10.1519/JSC.0b013e31828c289f

M3 - Article

VL - 27

SP - 3091

EP - 3100

JO - Journal of Strength and Conditioning Research

JF - Journal of Strength and Conditioning Research

SN - 1064-8011

IS - 11

ER -